Cargando…
INHIBITION OF PACLITAXEL AGAINST NEUROGLIOMA CELLS U251 GROWTH AND ITS MECHANISM
BACKGROUND: Glioma is the most common primary tumor of the central nervous system, and accounted for about 70% of primary tumors. MATERIALS AND METHODS: In the study, antitumour activity and mechanism of paclitaxel was investigated. Different concentrations of paclitaxel (200, 300, 400 μmol/L) was t...
Autores principales: | Xin, ShiMeng, Yu, Fang, Yang, ChunYan, Hao, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
African Traditional Herbal Medicine Supporters Initiative (ATHMSI)
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411869/ https://www.ncbi.nlm.nih.gov/pubmed/28480395 http://dx.doi.org/10.21010/ajtcam.v14i1.19 |
Ejemplares similares
-
miRNA-1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1
por: Gong, Jian, et al.
Publicado: (2017) -
Paclitaxel inhibits the migration of CD133+ U251 malignant glioma cells by reducing the expression of glycolytic enzymes
por: Long, Niya, et al.
Publicado: (2020) -
Patients treatment with neuroglioma by teniposide and semustine and its influence on Twist and E-cadherin expression
por: Zhang, Yongbo, et al.
Publicado: (2016) -
Effects of Connexin43 Overexpression on U251 Cell Growth, Migration, and Apoptosis
por: Lu, Jia, et al.
Publicado: (2017) -
Effect of Corilagin on the Proliferation and NF-κB in U251 Glioblastoma Cells and U251 Glioblastoma Stem-Like Cells
por: Yang, Wen-Tao, et al.
Publicado: (2016)